ipamorelin
Selected indexed studies
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (J Am Acad Orthop Surg Glob Res Rev, 2026) [PMID:41490200]
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. (Am J Sports Med, 2026) [PMID:41476424]
- Ipamorelin, the first selective growth hormone secretagogue. (Eur J Endocrinol, 1998) [PMID:9849822]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (2026) pubmed
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. (2026) pubmed
- Ipamorelin, the first selective growth hormone secretagogue. (1998) pubmed
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. (1999) pubmed
- The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus. (2024) pubmed
- The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. (2024) pubmed
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. (1999) pubmed
- Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus. (2009) pubmed
- The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. (2001) pubmed
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. (2020) pubmed